Efficacy of rituximab in patients with Graves’ orbitopathy: a retrospective multicenter nationwide study

被引:0
|
作者
Jean-Baptiste Deltour
Marie d’Assigny Flamen
Miriam Ladsous
Lama Giovansili
Bertrand Cariou
Philippe Caron
Delphine Drui
Pierre Lebranchu
机构
[1] CHU Nantes,Department of Ophthalmology, Hotel Dieu
[2] CHU Nantes,Department of Endocrinology Diabetes and Nutrition, L’institut du thorax
[3] Department of Endocrinology CHRU Lille,Department of Internal Medicine, Section of Endocrinology
[4] Fondation Ophtalmologique A de Rothschild,Department of Endocrinology, Metabolic Diseases and Nutrition, Pôle Cardio
[5] CHU Toulouse,Vasculaire et Métabolique
关键词
Rituximab; Anti-CD20 antibody; Graves’ orbitopathy; Basedow’s disease; Clinical activity score (CAS);
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2013 / 2021
页数:8
相关论文
共 50 条
  • [1] Efficacy of rituximab in patients with Graves' orbitopathy: a retrospective multicenter nationwide study
    Deltour, Jean-Baptiste
    Flamen, Marie D'Assigny
    Ladsous, Miriam
    Giovansili, Lama
    Cariou, Bertrand
    Caron, Philippe
    Drui, Delphine
    Lebranchu, Pierre
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2020, 258 (09) : 2013 - 2021
  • [2] The effects of Rituximab on Graves'orbitopathy: A retrospective study of 14 patients
    Eid, Laura
    Coste-Verdier, Valentine
    Longueville, Eric
    Ribeiro, Emmanuel
    Nicolescu-Catargi, Bogdan
    Korobelnik, Jean-Francois
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (05) : 1008 - 1013
  • [3] Rituximab in Graves' orbitopathy
    Kang, Seema
    LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (02): : 101 - 101
  • [4] Effects of rituximab in Graves' orbitopathy
    Salvi, Mario
    Vannucchi, Guia
    Beck-Peccoz, Paolo
    ENDOCRINE JOURNAL, 2010, 57 : S239 - S239
  • [5] Randomized Controlled Trial of Rituximab in Patients With Graves' Orbitopathy
    Stan, Marius N.
    Garrity, James A.
    Leon, Barbara G. Carranza
    Prabin, Thapa
    Bradley, Elizabeth A.
    Bahn, Rebecca S.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (02): : 432 - 441
  • [6] Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy
    Vannucchi, Guia
    Campi, Irene
    Covelli, Danila
    Curro, Nicola
    Lazzaroni, Elisa
    Palomba, Andrea
    Soranna, Davide
    Zambon, Antonella
    Fugazzola, Laura
    Muller, Ilaria
    Guastella, Claudio
    Salvi, Mario
    THYROID, 2021, 31 (05) : 821 - 828
  • [7] TOCILIZUMAB IN GRAVES' ORBITOPATHY. MULTICENTER STUDY OF 48 PATIENTS.
    Sanchez-Bilbao, L.
    Martinez-Lopez, D.
    Atienza-Mateo, B.
    Martin-Varillas, J. L.
    Calvo-Rio, V.
    Demetrio-Pablo, R.
    Calderon-Goercke, M.
    Prieto-Pena, D.
    Gonzalez-Mazon, I.
    Valls-Pascual, E.
    Valls-Espinosa, B.
    Maiz-Alonso, O.
    Blanco, A.
    Torre-Salaberri, I.
    Rodriguez-Mendez, V.
    Garcia-Aparicio, A.
    Veroz Gonzalez, R.
    Jovani, V.
    Peiteado, D.
    Castaneda, S.
    Sanchez-Orgaz, M.
    Muriel, E. Tomero
    Saenz de Miera, F. J. Toyos
    Pinillos, V.
    Aurrecoechea, E.
    Mora, A.
    Conesa, A.
    Fernandez, M.
    Troyano, J. A.
    Revenga, M.
    Hernandez, J. L.
    Gonzalez-Gay, A.
    Blanco, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 846 - 847
  • [8] Potential Utility of Rituximab for Graves' Orbitopathy
    Salvi, Mario
    Vannucchi, Guia
    Beck-Peccoz, Paolo
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (11): : 4291 - 4299
  • [9] Death by Suicide in Graves' Disease and Graves' Orbitopathy: A Nationwide Danish Register Study
    Ferlov-Schwensen, Charlotte
    Brix, Thomas Heiberg
    Hegedues, Laszlo
    THYROID, 2017, 27 (12) : 1475 - 1480
  • [10] MabThera use and efficacy in patients with active moderate to severe Graves' Orbitopathy: a multicentre retrospective study of 40 cases
    Lebranchu, P.
    Deltour, J. B.
    Cariou, B.
    Vabres, B.
    D'Assigny, M.
    Drui, D.
    ACTA OPHTHALMOLOGICA, 2017, 95